Urinary MCP-1 and RBP: Independent predictors of renal outcome in macroalbuminuric diabetic nephropathy

Journal of Diabetes and its Complications

Volumn 26, Issue 6, 2012, Pages 546-553

  Titan, S M ^a,b   Vieira Jr , J M ^a   Dominguez, W V ^a   Moreira, S R S ^b   Pereira, A B ^b   Barros, R T ^a   Zatz, R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chronic kidney disease; Diabetic nephropathy; MCP 1; RBP; TGF ; VEGF

Indexed keywords

CYTOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; RETINOL BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ARTICLE; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DIALYSIS; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; TREATMENT OUTCOME; URINALYSIS;

AGED; ALBUMINURIA; BIOLOGICAL MARKERS; CHEMOKINE CCL2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; RETINOL-BINDING PROTEINS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 84868643201     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2012.06.006     Document Type: Article

References (65)

1. R. Agarwal, S. Siva, S.R. Dunn, and K. Sharma Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels American Journal of Kidney Diseases 39 2002 486 492
2. B. Amann, R. Tinzmann, and B. Angelkort ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1 Diabetes Care 26 2003 2421 2425
3. C. Bazzi, C. Petrini, V. Rizza, G. Arrigo, P. Napodano, M. Paparella, and G. D'Amico Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis Nephrology, Dialysis, Transplantation 17 11 2002 1890 1896
4. T. Bobbert, J. Raila, and F. Schwarz Relation between retinol, retinol-binding protein 4, transthyretin and carotid intima media thickness Atherosclerosis 213 2 2010 549 551
5. N.O. Camara, M.S. Silva, and S. Nishida Proximal tubular dysfunction is associated with chronic allograft nephropathy and decreased long-term renal-graft survival Transplantation 78 2 2004 269 275
6. D.R. Cha, N.H. Kim, and J.W. Yoon Role of vascular endothelial growth factor in diabetic nephropathy Kidney International. Supplement 77 2000 S104 S112
7. Y.H. Chang, K.D. Lin, C.L. Wang, M.C. Hsieh, P.J. Hsiao, and S.J. Shin Elevated serum retinol-binding protein 4 concentrations are associated with renal dysfunction and uric acid in type 2 diabetic patients Diabetes/Metabolism Research and Reviews 24 8 2008 629 634
8. N. Chaturvedi, J.H. Fuller, and F. Pokras Circulating plasma vascular endothelial growth factor and microvascular complications of type 1 diabetes mellitus: the influence of ACE inhibition Diabetic Medicine 18 2001 288 294
9. F. Chiarelli, F. Cipollone, and A. Mohn Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes Diabetes Care 25 2002 1829 1834
10. Y.M. Cho, B.S. Youn, and H. Lee Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes Diabetes Care 29 11 2006 2457 2461
11. A.S. de Vriese, R.G. Tilton, M. Elger, C.C. Stephan, W. Kriz, and N.H. Lameire Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes Journal of the American Society of Nephrology 12 2001 993 1000
12. C. Donadio Serum and urinary markers of early impairment of GFR in chronic kidney disease patients: diagnostic accuracy of urinary β-trace protein American Journal of Physiology. Renal Physiology 299 6 2010 F1407 F1423
13. D. Ellis, K.Y. Forrest, J. Erbey, and T.J. Orchard Urinary measurement of transforming growth factor-beta and type IV collagen as new markers of renal injury: application in diabetic nephropathy Clinical Chemistry 44 5 1998 950 956
14. V. Eremina, J.A. Jefferson, and J. Kowalewska VEGF inhibition and renal thrombotic microangiopathy The New England Journal of Medicine 358 2008 1129 1136
15. V. Eremina, M. Sood, and J. Haigh Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases The Journal of Clinical Investigation 111 2003 707 716
16. L.M. Galanti, J. Jamart, J. Dell'omo, and J. Donckier Comparison of urinary excretion of albumin, alpha 1-microglobulin and retinol-binding protein in diabetic patients Diabetes & Metabolism 22 5 1996 324 330
17. D.M. Gibb, P.A. Tomlinson, N.R. Dalton, C. Turner, V. Shah, and T.M. Barratt Renal tubular proteinuria and microalbuminuria in diabetic patients Archives of Disease in Childhood 64 1 1989 129 134
18. R.E. Gilbert, A. Akdeniz, T.J. Allen, and J. Jerums Urinary transforming growth factor beta in patients with diabetic nephropathy: implications for the pathogenesis of tubulointerstitial pathology Nephrology, Dialysis, Transplantation 16 12 2001 2442 2443
19. A. Henze, S.K. Frey, J. Raila, M. Tepel, A. Scholze, A.F. Pfeiffer, M.O. Weickert, J. Spranger, and F.J. Schweigert Evidence that kidney function but not type 2 diabetes determines retinol-binding protein 4 serum levels Diabetes 57 12 2008 3323 3326
20. J. Holm, L. Hemmingsen, and N.V. Nielsen Relationship between the urinary excretion of albumin and retinol-binding protein in insulin-dependent diabetics Clinica Chimica Acta 177 1 1988 101 105
21. J. Holm, L. Hemmingsen, N.V. Nielsen, and N. Thomsen Increased urinary excretion of the retinol-binding protein in insulin-dependent diabetes mellitus in the absence of microalbuminuria Clinica Chimica Acta 170 2-3 1987 345 349
22. J. Holm, N.V. Nielsen, and L. Hemmingsen Retinopathy in type II diabetes mellitus associated with above-normal urinary excretion of RBP Kidney International. Supplement 47 1994 S105 S108
23. E.O. Honkanen, A.M. Teppo, and C. Gronhagen-Riska Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis Kidney International 57 2000 2343 2349
24. E. Honkanen, E. von Willebrand, and P. Koskinen Decreased expression of vascular endothelial growth factor in idiopathic membranous glomerulonephritis: relationships to clinical course American Journal of Kidney Diseases 42 2003 1139 1148
25. B. Hosaka, S.I. Park, and C.R. Felipe Predictive value of urinary retinol binding protein for graft dysfunction after kidney transplantation Transplantation Proceedings 35 4 2003 1341 1343
26. C.A. Houlihan, A. Akdeniz, C. Tsalamandris, M.E. Cooper, G. Jerums, and R.E. Gilbert Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restriction Diabetes Care 25 2002 1072 1077
27. P. Hovind, L. Tarnow, P.B. Oestergaard, and H.H. Parving Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy Kidney International. Supplement 75 2000 S56 S61
28. E. Ingelsson, and L. Lind Circulating retinol-binding protein 4 and subclinical cardiovascular disease in the elderly Diabetes Care 32 4 2009 733 735
29. C.G. Jungbauer, C. Birner, B. Jung, S. Buchner, M. Lubnow, C. von Bary, D. Endemann, B. Banas, M. Mack, C.A. Böger, G. Riegger, and A. Luchner Kidney injury molecule-1 and N-acetyl-β-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome European Journal of Heart Failure 13 10 2011 1104 1110
30. E.F. Kern, P. Erhard, W. Sun, S. Genuth, and M.F. Weiss Early urinary markers of diabetic kidney disease: a nested case-control study from the Diabetes Control and Complications Trial (DCCT) American Journal of Kidney Diseases 55 5 2010 824 834
31. H.J. Kim, H.S. Yoo, P.K. Kim, M.R. Kim, H.W. Lee, and C.W. Kim Comparative analysis of serum proteomes of patients with cardiovascular disease Clinical Biochemistry 44 2-3 2011 178 184
32. G.M. Kirsztajn, S.K. Nishida, M.S. Silva, H. Ajzen, L.A. Moura, and A.B. Pereira Urinary retinol-binding protein as a prognostic marker in glomerulopathies Nephron 90 4 2002 424 431
33. K.T. Koh, K.S. Chia, and C. Tan Proteinuria and enzymuria in non-insulin-dependent diabetics Diabetes Research and Clinical Practice 20 3 1993 215 221
34. A.S. Levey, D. Cattran, and A. Friedman Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration American Journal of Kidney Diseases 54 2 2009 205 226
35. J.F. Mann, R.E. Schmieder, and M. McQueen Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial The Lancet 372 9638 2008 547 553
36. T. Morii, H. Fujita, and T. Narita Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy Journal of Diabetes and its Complications 17 2003 11 15
37. T. Nakagawa, T. Kosugi, M. Haneda, C.J. Rivard, and D.A. Long Abnormal angiogenesis in diabetic nephropathy Diabetes 58 7 2009 1471 1478
38. M. Nangaku Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure Internal Medicine 43 1 2004 9 17
39. M. Nangaku Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure Journal of the American Society of Nephrology 17 1 2006 17 25
40. F.L. Nauta, W.E. Boertien, S.J. Bakker, H. van Goor, W. van Oeveren, P.E. de Jong, H. Bilo, and R.T. Gansevoort Glomerular and tubular damage markers are elevated in patients with diabetes Diabetes Care 34 4 2011 975 981
41. N.V. Nielsen, J. Holm, and L. Hemmingsen Diabetic retinopathy related to degree of albuminuria and tubular (low molecular weight) proteinuria in insulin-dependent (type I) diabetes mellitus Acta Ophthalmol (Copenh) 68 3 1990 270 274
42. A.B. Pereira, S.K. Nishida, and J.G. Vieira Monoclonal antibody-based immunoenzymometric assays of retinol-binding protein Clinical Chemistry 39 3 1993 472 476
43. B.A. Perkins, L.H. Ficociello, B. Roshan, J.H. Warram, and A.S. Krolewski In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria Kidney International 77 1 2010 57 64
44. P. Pontuch, T. Jensen, T. Deckert, P. Ondrejka, and M. Mikulecky Urinary excretion of retinol-binding protein in type 1 (insulin-dependent) diabetic patients with microalbuminuria and clinical diabetic nephropathy Acta Diabetologica 28 1992 206 210
45. P. Pontuch, E. Tçserová, J. Vozar, J. Bulas, and H. Kratochvílová 24-h ambulatory blood pressure, daytime and nighttime urinary albumin and retinol-binding protein excretion in type I diabetic patients Journal of Diabetes and its Complications 9 4 1995 234 236
46. E.W. Rivarola, M. Moyses-Neto, M. Dantas, C.G. Da-Silva, R. Volpini, and T.M. Coimbra Transforming growth factor beta activity in urine of patients with type 2 diabetes and diabetic nephropathy Brazilian Journal of Medical and Biological Research 32 12 1999 1525 1528
47. D.J. Rowe, F. Anthony, A. Polak, K. Shaw, C.D. Ward, and G.F. Watts Retinol binding protein as a small molecular weight marker of renal tubular function in diabetes mellitus Annals of Clinical Biochemistry 24 1987 477 482
48. M.A. Salem, S.A. el-Habashy, O.M. Saeid, M.M. el-Tawil, and P.H. Tawfik Urinary excretion of n-acetyl-beta-D-glucosaminidase and retinol binding protein as alternative indicators of nephropathy in patients with type 1 diabetes mellitus Pediatric Diabetes 3 1 2002 37 41
49. R. Sesso, R. Rettori, S. Nishida, E. Sato, H. Ajzen, and A.B. Pereira Assessment of lupus nephritis activity using urinary retinol-binding protein Nephrology, Dialysis, Transplantation 9 4 1994 367 371
50. R. Sesso, A.P. Santos, and S.K. Nishida Prediction of steroid responsiveness in the idiopathic nephritic syndrome using urinary retinol-binding protein and beta-2-microglobulin Annals of Internal Medicine 116 11 1992 905 909
51. K. Sharma, B.O. Eltayeb, and T.A. McGowan Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients American Journal of Kidney Diseases 34 1999 818 823
52. J.H. Song, S.H. Cha, and H.J. Lee Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease Nephrology, Dialysis, Transplantation 21 2006 683 689
53. StAR software Pontificia Universidad Católica de Chile. Molecular Bioinformatics Laboratory Available at http://protein.bio.puc.cl/cardex/servers/ roc/roc-analysis.php# 2011 Accessed February 14, 2011
54. I.E. Stillman, and S.A. Karumanchi The glomerular injury of preeclampsia Journal of the American Society of Nephrology 18 2007 2281 2284
55. K. Takebayashi, S. Matsumoto, and Y. Aso Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients Journal of Diabetes and its Complications 20 2006 98 104
56. K. Takebayashi, M. Suetsugu, S. Wakabayashi, Y. Aso, and T. Inukai Retinol binding protein-4 levels and clinical features of type 2 diabetes patients The Journal of Clinical Endocrinology and Metabolism 92 7 2007 2712 2719
57. R.G. Tilton, T. Kawamura, and K.C. Chang Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor The Journal of Clinical Investigation 99 1997 2192 2202
58. S.M. Titan, J.M. Vieira Jr., W.V. Dominguez, R.T. Barros, and R. Zatz ACEI and ARB combination therapy in patients with macroalbuminuric diabetic nephropathy and low socioeconomic level: a double-blind randomized clinical trial Clinical Nephrology 76 4 2011 273 283
59. V.S. Vaidya, M.A. Niewczas, and L.H. Ficociello Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D- glucosaminidase Kidney International 79 4 2011 464 470
60. T. Wada, K. Furuichi, and N. Sakai Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy Kidney International 58 4 2000 1492 1499
61. T. Wada, H. Yokoyama, K. Matsushima, and K. Kobayashi Monocyte chemoattractant protein-1: does it play a role in diabetic nephropathy? Nephrology, Dialysis, Transplantation 18 3 2003 457 459
62. C. Walton, H.J. Bodansky, J.K. Wales, M.A. Forbes, and E.H. Cooper Tubular dysfunction and microalbuminuria in insulin dependent diabetes Archives of Disease in Childhood 63 3 1988 244 249
63. G.F. Watts, M. Powell, D.J. Rowe, and K.M. Shaw Low-molecular-weight proteinuria in insulin-dependent diabetes mellitus: a study of the urinary excretion of beta 2-microglobulin and retinol-binding protein in alkalinized patients with and without microalbuminuria Diabetes Research 12 1 1989 31 36
64. V. Woo, L.S. Ni, and D. Hak Effects of losartan on urinary secretion of extracellular matrix and their modulators in type 2 diabetes mellitus patients with microalbuminuria Clinical and Investigative Medicine 29 2006 365 372
65. Q. Yang, T.E. Graham, and N. Mody Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes Nature 436 7049 2005 356 362